ASCO Daily News

134 Episodo

1. Novel Therapies in GI Oncology at ASCO22

   Publicado: 27/6/2022
2. Spotlight on Immunotherapy at ASCO22

   Publicado: 23/6/2022
3. Advances in Hematologic Malignancies at ASCO22

   Publicado: 22/6/2022
4. DESTINY-Breast04 and Other Key Breast Cancer Studies at ASCO22

   Publicado: 21/6/2022
5. Advances in Genitourinary Cancers at ASCO22

   Publicado: 18/6/2022
6. Advances in Lung Cancer at ASCO22

   Publicado: 17/6/2022
7. ASCO22 Scientific Program: Dynamic Sessions and Advances Across the Spectrum of Malignancies

   Publicado: 1/6/2022
8. ASCO22: Key Posters on Advances in Immunotherapy

   Publicado: 27/5/2022
9. ASCO22: Key Advances in Hematologic Malignancies

   Publicado: 27/5/2022
10. ASCO22: Novel Therapies in Breast Cancer

    Publicado: 27/5/2022
11. ASCO22: Key Posters on Advances in GI Oncology

    Publicado: 26/5/2022
12. ASCO22: Novel Therapies in Lung Cancer

    Publicado: 26/5/2022
13. Key Posters on Advances in GU Cancers at ASCO22

    Publicado: 26/5/2022
14. ASCO22: Addressing Challenges in Cancer Care With Dr. Neeraj Agarwal

    Publicado: 26/5/2022
15. ASCO22 Education Program Preview: Advancing Equity, Innovation, and Impact

    Publicado: 24/5/2022
16. Guidance on Cannabis Use in Palliative Oncology

    Publicado: 19/5/2022
17. How AA & NHPI Aggregation Masks Cancer Disparities

    Publicado: 5/5/2022
18. The Time Toxicity of Cancer Treatment

    Publicado: 21/4/2022
19. Highlights From the 2022 NCCN Annual Conference

    Publicado: 14/4/2022
20. Addressing the Needs of Millions of Cancer Survivors

    Publicado: 7/4/2022